Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study

Priya Gor(University of Pennsylvania Health System), Angela DeMichele(University of Pennsylvania), Michelle Horn(University of Pennsylvania), H. Irene Su(University of California San Diego), Richard Aplenc(Children's Hospital of Philadelphia), Robert J. Gray(University of Glasgow), Timothy R. Rebbeck(University of Pennsylvania), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), William P. Vaughan(University of Pennsylvania Health System), Phyllis A. Gimotty(University of Pennsylvania)
Breast Cancer Research
May 10, 2010
10.1186/bcr2570
Cited by 71

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
|Blood|2009|3.4k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k